QA: Dicerna Pharmaceuticals Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001399529_2021_Dicerna_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001399529, Dicerna Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 618,703,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 89,143,000
4 LiabilitiesCurrent 177,938,000
5 LiabilitiesNoncurrent 392,154,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 89,482,425
9 ResearchAndDevelopmentExpense 685,111,226
10 remainder_Expenses 13,391
11 remainder_Revenues 866,219,779
12 remainder_NetIncome 7,105,290
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 707,846,000
1 Liabilities 570,092,000
2 Expenses 774,607,042
3 Revenues 866,219,779
4 StockholdersEquity 137,754,000
5 NetIncome 98,718,027
6 ComprehensiveNetIncome 98,718,027
7 BaseVar 1,462,935,056
8 EconomicCapitalRatiobeforeLimitedLiability 0.624
9 EconomicCapitalRatio 1.99

Edgar->Model Mapping

Feature Distribution

Change over Time